CIK 0001280776 · Non-accelerated filer<br>Smaller reporting company
IMMUNIC, INC.
Sign in to watch- Ticker
- IMUX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562358443
- Phone
- (332) 255-9818
- Business address
- 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, United States, 10036
- Former names
- VITAL THERAPIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-04 | Muehler Andreas Chief Medical Officer | Grant or award · Stock Option | +259,000 | 259,000 | ||
| 2024-03-04 | Whaley Glenn Chief Financial Officer | Returned to the company · Stock Option | −15,000 | 0 | ||
| 2024-03-04 | Whaley Glenn Chief Financial Officer | Returned to the company · Stock Option | −15,000 | 0 | ||
| 2024-03-04 | Whaley Glenn Chief Financial Officer | Returned to the company · Stock Option | −30,000 | 0 | ||
| 2024-03-04 | Whaley Glenn Chief Financial Officer | Returned to the company · Stock Option | −40,000 | 0 | ||
| 2024-03-04 | Whaley Glenn Chief Financial Officer | Returned to the company · Stock Option | −70,000 | 0 | ||
| 2024-03-04 | Whaley Glenn Chief Financial Officer | Returned to the company · Stock Option | −40,000 | 0 | ||
| 2024-03-04 | Whaley Glenn Chief Financial Officer | Returned to the company · Stock Option | −10,000 | 0 | ||
| 2024-03-04 | Whaley Glenn Chief Financial Officer | Grant or award · Stock Option | +220,000 | 220,000 | ||
| 2024-03-04 | Neermann Joerg Director | Returned to the company · Stock Option | −29,959 | 0 | ||
| 2024-03-04 | Neermann Joerg Director | Returned to the company · Stock Option | −15,000 | 0 | ||
| 2024-03-04 | Neermann Joerg Director | Returned to the company · Stock Option | −10,000 | 0 | ||
| 2024-03-04 | Neermann Joerg Director | Returned to the company · Stock Option | −10,000 | 0 | ||
| 2024-03-04 | Neermann Joerg Director | Grant or award · Stock Option | +64,959 | 64,959 | ||
| 2024-03-04 | Toernsen Monika Maria Director | Returned to the company · Stock Option | −30,000 | 0 | ||
| 2024-03-04 | Toernsen Monika Maria Director | Grant or award · Stock Option | +30,000 | 30,000 | ||
| 2024-02-26 | Vitt Daniel President and CEO | Purchase | +14,000 | $1.31 | $18K | 390,877 |
| 2024-01-17 | Nash Duane Executive Chairman | Grant or award · Stock Option | +300,000 | 300,000 | ||
| 2024-01-17 | Vitt Daniel Chief Executive Officer | Grant or award · Stock Option | +1,160,000 | 1,160,000 | ||
| 2024-01-17 | Muehler Andreas Chief Medical Officer | Grant or award · Stock Option | +335,400 | 335,400 |
Page 7 of 9 · 170 trades